Suicidal behaviors are very rare in antiparkinsonian drug trials.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2015-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.parkreldis.2015.06.011PMID 26096798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myths and facts about the EARLYSTIM study

  2014cited by this paper
• Neurostimulation for Parkinson's disease with early motor complications.

  2013cited by this paper
• Neurostimulation for Parkinson's disease with early motor complications.

  2013cited by this paper
• A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease.

  2008influential reference
• Are Patients with Parkinson's Disease Suicidal?

  2001cited by this paper
• Are patients with Parkinson's disease more likely to have periventricular hyperintensities develop?

  1996cited by this paper
• Depression and Parkinson's disease: a review.

  1992cited by this paper

• Benztropine and suicide attempts and intentional self-harm.

  2023cites this paper
• Reader response: Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study

  2020cites this paper
• Editors' note: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial

  2020cites this paper
• Reader response: Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial

  2020cites this paper
• Disputes & Debates: Editors’ Choice

  year unknowncites this paper